Mesodermal Cell Induction via Signaling Pathway Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a unified mesoderm germ layer developmental roadmap and improved methods for the efficient in vitro patterning of mesoderm cells from pluripotent progenitors, as well as rapid and efficient induction and purification of highly homogeneous populations of mesoderm lineages.
Innovation Solution
The methods involve contacting pluripotent progenitor cells with specific induction compositions that activate or inhibit various signaling pathways, such as TGF-beta, Wnt, FGF, BMP, and PI3K pathways, to produce lineage-restricted mesodermal progenitor populations or differentiated mesodermal cell types, including anterior primitive streak, paraxial mesoderm, somites, sclerotome, dermomyotome, and cardiac mesoderm cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional methods are used for in vitro patterning of mesoderm cells from pluripotent progenitors, then the process is simpler, but the efficiency and homogeneity of mesodermal cell population generation are insufficient
Solution Approach 1:
The patent applies parameter changes by systematically varying the concentrations and combinations of signaling pathway modulators (TGF-beta, Wnt, FGF, BMP, PI3K) in induction compositions to optimize mesodermal cell generation efficiency. Different stages of mesoderm differentiation require specific parameter settings of these molecular signals, enabling high-yield production of homogeneous mesodermal populations while managing composition complexity through staged optimization.
Solution Approach 2:
The patent uses small molecule modulators as intermediaries to translate complex signaling pathway interactions into controlled cellular responses. These intermediaries (chemical compounds that activate or inhibit specific pathways) mediate the conversion from pluripotent state to mesodermal fate, enabling precise control over differentiation efficiency without requiring direct manipulation of multiple signaling pathways simultaneously.
2Loss of time
If rapid induction of mesoderm lineages is achieved, then the time required is reduced, but the purity and homogeneity of cell populations may be compromised
Solution Approach 1:
The patent employs preliminary action by pre-designing staged induction protocols where specific signaling pathway modulators are introduced in predetermined sequences and concentrations. This preliminary planning of the differentiation trajectory enables rapid progression through mesodermal stages while maintaining population homogeneity, as each stage is pre-optimized to produce the desired cell type without contamination from alternative lineages.
Solution Approach 2:
The patent segments the mesoderm induction process into distinct temporal and compositional stages, where different combinations of pathway modulators are applied at different time points. This segmentation allows rapid progression through early mesodermal commitments while subsequent stages refine population homogeneity, achieving both speed and purity through divided processing steps.
3Manufacturing precision
If a unified developmental roadmap is implemented, then the patterning precision is improved, but the protocol complexity increases
Solution Approach 1:
The unified developmental roadmap implements systematic parameter changes across defined time points, where concentrations and combinations of signaling modulators are precisely adjusted to guide mesodermal differentiation through predetermined stages. This parameter-based control achieves high patterning precision by mapping specific molecular conditions to specific developmental outcomes, while the standardized parameter sets across stages reduce overall protocol complexity through repeatability.
Data Source
AI summary
Methods are provided for the generation of mesodermal cell types and derivatives thereof. Also provided are methods for generating purified populations of mesodermal cell types and derivatives thereof. The instant disclosure also provides methods of screening for cellular responses of the generated mesodermal cell types and derivatives thereof. Also provide are methods for screening for organismal phenotypes induced by introduction of the generated mesodermal cell types and derivatives thereof. Treatment methods making use of the generated mesodermal cell types and derivatives thereof are also provided. The instant disclosure also provides systems, compositions, and kits for practicing the methods of the disclosure.